These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7167246)

  • 1. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
    Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzymatic therapy in hepatology with ornithine carbamol transferase].
    Monges H; Hancy A; Codinach N
    Mars Med; 1971; 108(12):881-5. PubMed ID: 5145506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hepatocellular insufficiency with ornithine carbamyl transferase].
    Heully F; Gaucher P; Jeanpierre R
    Therapeutique; 1972; 48(5):381-4. PubMed ID: 5076530
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-biological therapeutic effect of intramuscular ornithine-carbamyl-transferase in chronic active hepatitis].
    Sanchís Closa A; Caballería Rovira E; Arago López JV; Massó Ubeda RM
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):351-4. PubMed ID: 3387645
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activity of guanase and ornithine carbamyl transferase in blood serum of patients with liver disease].
    Boroń P; Kucharski C; Prokopowicz D; Kossakowski R; Neczyperowicz J
    Przegl Lek; 1972; 29(7):675-9. PubMed ID: 5073033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ornithine carbamyl transferase (S-OCT)--interpretation of the test results].
    Takeda H; Kamano T; Kamiyama Y; Honko I
    Nihon Rinsho; 1973; 31():1794-801. PubMed ID: 4795308
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of hepatic lesions in hyperthyroid conditions by means of determination of serum ornithine-carbamyl-transferase].
    Bonera E; Bertoni P
    Quad Sclavo Diagn; 1974 Dec; 10(4):509-14. PubMed ID: 4156600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The valve of the determination of the ornithine-carbamyl transferase in the serum and its comparison with the determination of the glutamo-pyruvic transaminase in clinical hepatology].
    Cachin M; Girard ML; Charbonnier A; Rousselet F; Koch M; Khoury K
    Pathol Biol; 1965 May; 13(9):477-88. PubMed ID: 5320274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of the determination of serum ornithine-carbamoyl transferase and of sulfobromophthalein clearance in the laboratory diagnosis of chronic liver diseases].
    Ceriotti G; Zotti S; Bonini PA
    Quad Sclavo Diagn; 1971 Dec; 7(4):1192-212. PubMed ID: 5161741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 16. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 17. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 18. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa].
    Svacinka P; Horký J; Blahníková L
    Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z; Korolko A
    Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new multienzyme complex. Clinical trial in hepatitis and cirrhosis].
    Ribet A; Vidal JL
    Nouv Presse Med; 1972 Nov; 1(42):2843-4. PubMed ID: 4663747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.